CLYMCLIMB BIO INC
CUSIP 28658R106 · common stock
3 tracked investors held CLIMB BIO INC (CLYM) at the end of Q3 2026, worth $125.8M in total. The largest holder was RA Capital Management, with 1.2% of its portfolio. Ken Fisher opened a new position this quarter.
Holders · Q3 2026
3
New holders
1
Value held
$125.8M
Quarter-end price (est.)
$11.47
Investors holding CLYM · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 1.17% | 10,130,130 | $116.2M | REDUCE-10.4% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.39% | 792,936 | $9.1M | REDUCE-3.6% |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 43,996 | $504.6K | NEW |